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Abstract
BACKGROUND
There is growing empirical evidence supporting theories of developmental origins of
health and disease (DOHaD). However, the implications of DOHaD conjectures for ag-
gregate population patterns of human disease, disability, mortality, and aging are poorly
understood.
OBJECTIVE
We empirically test two predictions derived from a formal model of aggregate population-
level impacts of DOHaD. This model predicts that populations potentially influenced by
delayed effects should experience singularities in their adult mortality patterns that can
be empirically detected from aggregate data.
METHODS
We test predictions using a large mortality database for populations in the Latin American
and Caribbean (LAC) region, spanning nearly one hundred years of mortality history.
RESULTS
Results are consistent, within explicit bounds of uncertainty, with expected patterns. We
find that younger cohorts in countries whose mortality decline starts more recently expe-
rience deceleration in survival gains at older ages, attenuation of the rate of aging at older
ages, and a decline in the association between early childhood and adult mortality.
CONCLUSIONS
Results point to the importance of adverse early conditions for human longevity. Fu-
1 All authors contributed equally.
2 Population Studies Center, University of Pennsylvania, Philadelphia, USA. Email: verhulst@sas.upenn.edu.
3 Department of Community Health Sciences, Fielding School of Public Health and California Center for
Population Research, UCLA, Los Angeles, USA. Email: beltrans@ucla.edu.
4 Labor and Population Unit, RAND Corporation and Center for Demography and Health of Aging, University
of Wisconsin–Madison, USA. Email: palloni@ssc.wisc.edu.
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ture research should shed light on the impact on morbidity, disability, and healthy life
expectancy.
CONTRIBUTION
To our knowledge this is the first time that implications of DOHaD conjectures for popu-
lations’ mortality patterns are formulated precisely and empirically tested with aggregate
population data.
1. Introduction
In the last decade or so, research guided by the Developmental Origins of Health and
Disease (DOHaD) paradigm and related theories has grown rapidly (Bateson and Gluck-
man 2011; Gluckman and Hanson 2005, 2006; Rosenfeld 2008). While the original idea
of delayed adult effects of early childhood conditions has been around for quite some
time and in very disparate strands of the literature (Derrick 2006; Frost 1939; Kermack,
McEndrick, and McKinlay 1934; Preston and van de Walle 1978), it was Barker’s work
on “fetal programming” that provided the initial impetus for the creation of what is now a
very active field of empirical research (Barker 1998, 2012; Hales and Baker 2001; Lucas
1991). Ecological and epidemiological studies, natural experiments, as well as animal
studies under controlled conditions, provide an array of evidence supporting DOHaD’s
key predictions. However, the implications of DOHaD for aggregate population patterns
of human health, disability, and mortality have been neither rigorously formulated nor
empirically tested. In this paper we contribute to fill this vacuum. First, we rely on a
formal model of relations between early conditions and adult health and mortality conjec-
tured by DOHaD to derive a handful of predictions. Second, we use a long time series of
cohort mortality in countries of the Latin American and Caribbean (LAC) region, whose
populations, we argue, are primed to manifest the impact of early conditions, to test two
of the model predictions.
The plan of the paper is as follows: In Section 2 we briefly review mechanisms posed
by DOHaD and related theories. Section 3 describes implications of delayed effects for
human adult mortality patterns. Section 4 presents predictions and conditions of observ-
ability. Section 5 describes selected characteristics of our case study. Section 6 reviews
the data and models. Section 7 discusses results and draws inferences. In the final section
we summarize, highlight limitations, and identify future lines of research.
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2. Background: Mechanisms for adult delayed effects
A diverse set of mechanisms could transform episodic or recurrent early exposures in
utero, perinatally, and during infancy and early childhood into delayed impacts on adult
illness, disability, and mortality. The mechanisms are associated with organ-specific em-
bryo and fetal cell growth and differentiation (Bateson and Gluckman 2011; Gluckman
and Hanson 2005, 2006), epigenetic changes (Gluckman, Buklijas, and Hanson 2016;
Godfrey et al. 2007; Kuzawa and Eisenberg 2014; Meaney 2010), exposure to and con-
traction of early childhood diseases and sustained inflammation (Crimmins and Finch
2006; Elo and Preston 1992; Finch and Crimmins 2004; Fong 2000), and experiences
with stressful conditions and environments (McEwen 1998; Meaney 2001, 2010). Fur-
thermore, a large and influential body of empirical research documents the long-lasting
impact of early nutritional status on adult health and mortality (Costa 2000; Fogel 2004;
Scrimshaw 1997; Scrimshaw and SanGiovanni 1997). Finally, there is widespread em-
pirical evidence demonstrating that more diffuse exposures, such as poverty and severe
deprivation in infancy and early childhood, can also have lasting impacts (Bengtsson and
Lindstro¨m 2012; Forsdahl 1987, 2002).
The mechanisms identified above are the focus of various strands of theories with
unique histories and distinct disciplinary foundations. Different as they may be, how-
ever, they share an important trait as all invoke perturbations during critical periods of
the development of a phenotype triggered by insults before conception, during embry-
onic and fetal life, perinatally, and across early stages of physical and cognitive growth.
These early insults may then lead to disruptions in processes of organ growth, differenti-
ation, and function; immune response; neurological development; metabolic regulation;
and even the formation of adult preferences and behaviors. After variable but usually
prolonged latency periods, the disruptions could manifest themselves as increased sus-
ceptibility to adult chronic illness.
This shared feature emphasized by multiple variants of DOHaD coexists with im-
portant differences that segregate them into distinct classes associated with different out-
comes. For example, mechanisms that depend on epigenetic changes, such as methylation
of CpG islands caused by nutrient deficiencies, disrupt metabolic function and are asso-
ciated with child and adult obesity (Vickers 2014; Yajnik 2014). Others involve organ
damage caused by an immune overresponse to bacteria, as in the case of acute rheumatic
heart fever that increases the risk of adult heart valve stenosis (Sika-Paotonu et al. 1980).
And yet others depend on misfiring of the HPA axis, an adaptation among some mam-
mals to chronic stress, as when early abuse triggers adult depression, aggressiveness, and
anxiety (Meaney 2010). The differences between these mechanisms range over a number
of domains, including nature and timing of insults, critical and sensitive periods, chronic
illnesses, critical ages after which the damage is manifested, and interactions between
initial insults and individuals’ lifetime exposure to different environments.
http://www.demographic-research.org 1169
Verhulst, Beltra´n-Sa´nchez & Palloni: Impact of delayed effects on human old-age mortality
Because these mechanisms are complex and their biological underpinnings are poorly
understood, we are ill-equipped to trace precisely the pathways from exposure to final
outcomes at the level of individuals, let alone discern different effects for entire popu-
lations. Thus, it is inevitable to embark on the initial investigation of population level
impacts of delayed effects ignoring differences between mechanisms and focus only on
their gross, overall impact on patterns of health and mortality. Although this is a simplifi-
cation to circumvent lack of precise knowledge about the processes involved – not unlike
omitting considerations of mediating pathways in causal analysis – it has an important
payoff in that it enables us to identify the nature of processes that must be elucidated to
understand long-term impacts irrespective of the mechanism conveying adult health man-
ifestations. Given this simplification, and for the sake of terminological compactness, we
adopt two abbreviations throughout. First, we use the term ‘delayed effects’ as shorthand
for ‘delayed adult health, disability, and mortality effects’ associated with one or multi-
ple mechanisms that link early conditions and adult diseases and mortality, irrespective
of the nature of the chronic illness(es) involved. Second, we use the acronym DET (De-
layed Effects Theories) as shorthand to refer to DOHaD and related theories, regardless
of differences between the mechanisms that each of them prioritizes. We are mindful of
the heterogeneous nature of this body of theories and, when precision is needed, we will
abandon the shorthand.
3. Implication of delayed effects for human adult mortality patterns
Assume that one or a combination of DET theories conjecturing the existence of delayed
effects associated with early exposures is correct. The question of interest for popula-
tion health sciences is about the implications of different regimes of early exposures for
population levels and patterns of adult health, disability, and mortality: If birth cohorts in
different populations are exposed to heterogeneous regimes of early adverse conditions,
how are these manifested in adult age patterns of morbidity, disability, and mortality?
This question has been addressed before but at different levels of aggregation. Thus,
there are well-known studies of adult effects of exposures to exceptional shocks among
members of single birth cohorts, such as the survivors of famines (Lumey et al. 2012), and
those exposed to natural disasters (Cao-Lei et al. 2014), and epidemics (Almond 2006).
In addition, there is a rich body of epidemiological studies on the impact of more gradual,
less acute, early experiences among individual members of single birth cohorts (Kuh and
Ben-Shlomo 1997).
The approach we adopt in this paper is different from those above in that we focus
on outcomes for entire populations. First, we formulate precisely the question posed at
the outset by resorting to a formal model of DET that yields predictions about expected
impacts of birth cohorts’ early experiences on their adult mortality patterns. These pre-
1170 http://www.demographic-research.org
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dictions are for entire populations, not for single individuals. Second, we focus on the
historical experience of about 25–30 birth cohorts in each of 18 populations in LAC. As
a strategy to identify footprints of adverse early conditions on adult mortality patterns,
we exploit heterogeneity of early childhood mortality to which these birth cohorts were
exposed. The formal model helps us to define precisely distinct features of adult-age pat-
terns of mortality that should be observed if DET theories are correct; that is, it specifies
expected manifestations of a cohort’s adverse early exposures on their adult mortality
patterns. The model also identifies empirical conditions that must be met for an observer
to be able to detect such impacts in commonly available empirical data. In the section
below we review these predictions and identify the empirical conditions.
4. Predictions and conditions of observability
We seek answers to the following question: How do age patterns of adult mortality in
populations influenced by early conditions differ from those in which early conditions
have no bearing on adult mortality? To provide answers, we formulate a model that de-
fines with precision the most important relations between early exposures and different
cohorts’ late mortality. These relations are simplified representations of multiple mecha-
nisms proposed by DET theories and a summary of them is included in Appendix 1.5
An important feature of the model is the distinction between background and ob-
served age patterns of mortality. A population’s background mortality pattern is the set
of age-specific death rates to which successive birth cohorts are exposed throughout their
lives in the absence of delayed effects. It is a function of a fixed standard set of age-
specific mortality rates that applies to all birth cohorts and a drift or mortality decline
that reduces the level of mortality rates at all ages for successively born cohorts. In the
absence of delayed effects, all birth cohorts should experience a fixed rate of senescence
(rate of growth of adult mortality rates or Gompertz slope) and exhibit a fixed relation be-
tween mortality at early and older adult ages, both embedded in the background pattern
of mortality.
A birth cohort’s observed mortality pattern, on the other hand, is what the investi-
gator would retrieve and measure from vital statistics. In the absence of delayed effects,
background and observed age patterns of mortality should be identical. However, the
presence of delayed effects will generate differences between background and observed
mortality patterns, much as changes in the composition of a cohort by frailty induces dif-
ferences between the baseline and the average, observed age pattern of mortality (Vaupel
and Missov 2014). For delayed effects to be observable, however, the background mor-
tality pattern must be disturbed by a mortality decline so that more recently born birth
5 The full model is described elsewhere (Palloni and Beltra´n-Sa´nchez 2016, 2017).
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cohorts experience better survival prospects at all ages, particularly in early childhood.
Stationary mortality levels will not produce observable signs of delayed effects in ag-
gregate mortality data even if individual members of birth cohorts are affected by them
(Palloni and Beltra´n-Sa´nchez 2016, 2017).
4.1 Predictions
We focus on two of the five predictions generated by the formal model.
Prediction 1: On changes on the rate of adult mortality decline
Under some conditions we describe in detail below, a secular mortality decline generates
a growing influx of surviving individuals at all ages who are more susceptible to express
delayed effects after attaining some (adult) critical age. As a consequence of this, the
observed pace of adult mortality decline of successive birth cohorts will decelerate and
drop below the rate of background mortality decline.6
Prediction 2: On distortions of the age pattern of mortality
If and when the secular mortality decline generates a growing influx of survivors primed
to expressed delayed effects, the relation between early childhood and adult mortality
rates will change as follows:
(2.1) The observed within-cohort association between child mortality and adult mortality
will decline in absolute value even if the association in the background mortality
regime remains invariant.
(2.2) The observed within-cohort association between child mortality and the adult mor-
tality slope (rate of senescence of the age pattern of mortality) will be attenuated
and converge to zero among the more recently born cohorts even though the older
adult background mortality pattern remains invariant.
An additional implication of the model (prediction 3) that helps us leverage data
to test predictions 1, 2.1, and 2.2 is the following: Differences between observed and
expected patterns implied by these predictions must be more pronounced in populations
whose mortality decline is more rapid, more strongly dependent on survival gains at very
young ages, and driven by reduction of fatality rates of communicable diseases rather than
6 Note that the prediction refers to the rate of adult mortality decline only, not to the rate of decline of mortality
at younger ages which could remain unaffected. This is a key difference between our model and a classic model
with unobserved heterogeneity (Palloni and Beltra´n-Sa´nchez 2016, 2017).
1172 http://www.demographic-research.org
Demographic Research: Volume 40, Article 41
by amelioration of standards of living, better maternal health, and improved maternal and
child nutrition.
4.2 Conditions for the observability of delayed effects
The manifestation of delayed effects on mortality patterns – differences between observed
and background mortality – will be detectable only if some conditions are met. The first
three conditions are ‘hard’ in that, when not met, there will be no observable traces of
delayed effects on adult mortality patterns. The last condition is ‘soft’ and, if not met, the
signals of delayed effects will be dimmer but not necessarily absent.
(1) Survival to critical ages:
A nontrivial fraction of members of a birth cohort who experience early insults sur-
vive beyond some critical age Y1 after which manifestations of the original damage
begin to unfold, e.g., if Y1 is too high, there will be weak or no observable delayed
effects.
(2) Growing fraction of infant and children surviving to critical ages:
The (background) secular mortality decline is sustained by improvements in infant
and child survival that increase the fraction of successive cohorts surviving to crit-
ical ages, e.g., if mortality improvements influence only older adult mortality, no
delayed effects will be observed in aggregate data. Some types of child mortality
decline are stronger promoters of increased adult susceptibility to delayed effects
than others. Thus, a mortality decline whose root cause is reductions of fatality
rates of communicable diseases, more so than improvements in nutritional status or
declining exposure to diseases, promotes increases in the adult prevalence of indi-
viduals who were exposed to early nutritional deprivation and/or to repeated bouts
of illnesses. These types of secular mortality declines are characteristic of post-
1950 low- and middle-income countries in general and LAC in particular (Palloni
and Pinto 2011; Preston 1980).
(3) Moderately sized excess fatality rates:
Delayed effects must be associated with higher than average morbidity or mortality
risks for a broad range of illnesses and conditions with nontrivial impacts.
(4) Neutral improvements of medical technology:
The beneficial effects related to mortality (morbidity) of medical improvements
adopted between the time of onset of each birth cohort’s early experiences and the
time at which its members attain the critical age Y1 fail to offset excess mortality
risks due to chronic illnesses associated with delayed effects.
A schematic summary of these conditions is in Table 1. The first two conditions are
straightforward. Adult delayed effects will only be observable if a significant fraction of
http://www.demographic-research.org 1173
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those who are most susceptible to express them survive beyond ages at which delayed
effects manifest themselves.
Because it is likely that individuals most exposed to adverse early conditions are
those who also experience more elevated mortality risks than the average, the condition
requires that the excess mortality that these subpopulations experience (perhaps in ado-
lescence or later but before critical ages) is not offset by gains associated with the secular
mortality decline. Only when there is a nontrivial offsetting effect will we observe an
increase in the proportional contribution of individuals most exposed to adverse early
conditions to the population surviving past a critical age.
The second condition requires that successive birth cohorts experience gradual in-
creases in the fraction of individuals most susceptible to express delayed effects who
survive to critical ages. The third condition states that delayed effects are irrelevant if
they are expressed only via rare diseases and disorders or by illnesses with low fatality
rates. Finally, the fourth condition requires that gains in adult survival due to medical im-
provements that reduce fatality rates of chronic illnesses associated with delayed effects
should not swamp the expected excess mortality triggered by them. While the first three
conditions are likely to be met in populations that experienced secular mortality declines
such as those in LAC countries, the last one is less so. As a consequence, unless the im-
pacts of medical improvements are accounted for, estimates of the magnitude of delayed
effects on mortality will always be understated.7
Table 1: Conditions for observability of delayed effects on adult mortality
patterns
Condition Expected effect of the condition
1. Survival to critical ages is nontrivial The probabilities of surviving to critical ages must be nontrivial or,
equivalently, the critical ages cannot exceed certain ages for which
survival probabilities are very low.
2. Nature of secular mortality decline Successive increases in the fraction of adult population who survived
past critical ages and experienced early deprivation.
3. Magnitude of adult fatality rates The fatality rates of chronic illnesses associated with deprivations
experienced early in life are nontrivial.
4. Influence of medical technology The magnitude of reduction in fatality rates associated with adult
chronic illnesses affected by early conditions is not large enough to
offset increases due to a larger influx of population susceptible to
them by virtue of their earlier experience.
7 It should be noted that the fourth condition applies only to mortality. If one is assessing the impact of early
conditions on the prevalence of chronic illnesses rather than fatality rates, the condition does not apply. For
example, it is known that poor nutrition in utero may prime individuals for adult metabolic disorders. If the
excess mortality implied by some of these disorders (e.g., T2D) is offset by medical improvements, the impact
of an increased flow of individuals who experienced in utero deprivation will not be observable. But, regardless
of how beneficial medical technologies that reduce T2D fatality rates are, the prevalence of T2D will increase.
1174 http://www.demographic-research.org
Demographic Research: Volume 40, Article 41
4.3 Implications of delayed effects: A summary
The discussion above suggests that in populations susceptible to delayed effects that meet
a handful of conditions, cohorts’ adult mortality patterns may experience deformations
(Fridlizius 1989). When mortality decline occurs in a population primed for delayed
effects (e.g., with a significant pool of susceptible individuals), the potential exists for
large, albeit lagged, increases of the fraction of individuals surviving past the critical age
Y1 who are scarred by adverse early experiences. To the extent that these experiences
manifest into adult mortality excesses, they will result in reductions of the rate of change
of adult mortality for the corresponding birth cohorts. This could halt or slow down
improvements in adult mortality even if background mortality is declining at a constant
rate. In addition, the rate of age-dependent growth of older adult mortality will change
over time even if the age pattern of background mortality is invariant. In the very long run,
when the effects of improvements of mortality before critical ages run their course, these
deformations of cohort mortality will subside and a new background mortality pattern
with no memory of past experiences will be established.
The expected deformations of birth cohorts’ adult mortality patterns described above
are analogous to those produced by changes in composition by frailty in the absence
of delayed effects. The difference between the two regimes is that while changes in
composition by frailty with no delayed effects can never reverse a mortality decline and
leaves imprints in the rate of decline of mortality rates at all ages, the impact of delayed
effects could reverse a mortality decline but will do so only at ages older than the critical
age.
Finally, although we do not investigate it in this paper, the impacts alluded to above
may be amplified if, as is the case in most low- to middle-income countries, there are rapid
and profound dietary and lifestyle changes that increase discordance between embryonic,
uterine, and post-birth environments (Bateson et al. 2004; Bateson and Gluckman 2011).
Birth cohorts who experience such discordance could be exposed to more severe adult
expression of delayed effects than when there are long time lags between the experience
of deleterious pre-conception, embryonic, or fetal environments and profound shifts in
post-natal conditions.
5. Case study
We test predictions using the mortality experiences of countries of the Latin American
and Caribbean (LAC) region during the period 1900–2015. The main attributes of the
mortality decline in the LAC region potentiate the expression of delayed effects and pro-
vide some opportunities to detect evidence of perturbations of cohorts’ mortality patterns
described in predictions 1, 2.1, and 2.2.
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5.1 Mortality decline in LAC
Two features of mortality decline in LAC are of interest. First, it was fast, and its ini-
tial driver was a disproportionate reduction of early childhood mortality. As Figure 1
shows, the contours of child mortality decline in three groups of LAC countries: fore-
runners, intermediate, and laggards (see definitions below). Second, the bulk of the de-
cline that affects cohorts born between 1935 and 1970 is associated with the post-1935
wide dissemination of sulfas, penicillin, antibiotics, and eradication of parasitic diseases.
Any change in mortality before the widespread dissemination of sulfas and antibiotics
(roughly before 1935/1940) must be associated with either improvements in standards
of living (housing, nutrition), advances in infrastructure (water, sewage, electricity), or
massive public health interventions (eradication campaigns). These changes improved
survival by changing maternal and fetal nutrition and by diminishing the risks of expo-
sure to and contraction of infectious and parasitic diseases. Cohorts born after 1935 in
countries that had not yet experienced these structural changes benefitted mostly from
survival gains associated with diffusion of chemotherapies. Of lesser importance were
changes in conditions that influenced maternal and fetal nutrition or the opportunities for
exposure to infectious and parasitic diseases. Thus, being born after 1935 is tantamount
to being exposed to a ‘treatment’ that could result in increases in the fraction of a birth
cohort’s adult survivors who are more susceptible to expressing delayed effects. This
change occured because these cohorts benefitted from survival gains even if their expo-
sure to adverse conditions (early nutrition, maternal health, diseases, ecology) remained
largely unchanged. Previous research suggests that a fraction exceeding 40–60% of the
mortality decline that followed the end of World War II in LAC is due to the dissemination
of new medical technologies that first reduced the fatality rates of communicable diseases
and then helped to attenuate exposure to them (vaccination and eradication campaigns)
(Palloni and Pinto 2011; Palloni and Wyrick 1981; Preston 1980).
Timing of birth (pre- and post-1935) is an appealing but very blunt indicator of a
cohort’s potential to manifest delayed effects. A more useful indicator can be constructed
by combining the timing of birth with the cohort’s country of origin. This is because LAC
countries experienced two very different regimes of mortality decline. A group of coun-
tries (‘forerunners’) began an early mortality decline that was fueled throughout, except
perhaps in late stages after 1970, by socioeconomic improvements, including ameliora-
tion of standards of living, infrastructure, and sanitation. In contrast, the mortality decline
in a second group of countries (‘laggards’) begins much later and, except at its tail end, is
mostly driven by dissemination of antibiotics and eradication campaigns. All post-1950
birth cohorts are influenced to some degree by the advent of new medical technologies,
but those born in laggard countries are much more influenced than those born in fore-
runner countries (Palloni, Beltra´n-Sa´nchez, and Pinto 2016). Thus, combining timing of
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birth and country of origin leads to a more useful, albeit still primitive, indicator of a
cohort’s potential to manifest delayed effects.
Figure 1: Time trends in childhood mortality rates (5q0) for Latin American
countries by timing of onset of mortality decline
Year
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Source: LAMBdA (http://www.ssc.wisc.edu/cdha/latinmortality).
5.2 Classification of birth cohorts
Following the above discussion and to facilitate testing of the two global predictions, we
classify birth cohorts according to two criteria. The first criterion is the cohort’s year of
birth. Child survival of cohorts born early in the century (before 1935) could not pos-
sibly have benefited from factors other than improved nutrition and sanitation and are
less likely to manifest delayed effects. Instead, cohorts born more recently, particularly
after the end World War II, are more likely to have experienced substantial gains due to
medical innovations, in some cases in combination with improvements in standards of
living. The second criterion is whether or not a cohort’s country of birth experiences the
onset of a secular mortality decline before or after the widespread application of medical
technologies (circa 1935). This is a device to distinguish epidemiological regimes where
it was possible to attain gains in survival through improvements in standards of living
(forerunner countries whose mortality decline began circa 1925–1935) from those where
the onset of mortality decline followed the dissemination of new medical technologies
(laggard countries whose mortality decline began after 1945–1950). The former coun-
tries’ mortality decline is more gradual and less dependent on improvements in childhood
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survival. The latter countries’ mortality decline is sharper and tightly connected to reduc-
tions of infant and child mortality. These two criteria – a cohort’s timing of birth and the
country’s timing of the onset of mortality decline – lead to a simple classification of birth
cohorts under observation, portrayed in Figure 2. Cohorts in quadrants A and B include
forerunner countries (N = 9) that begin their mortality decline early in the century, cer-
tainly before 1935 (Figure 1); countries in quadrants C and D include laggard countries
(N = 9) whose mortality decline begins in earnest only after 1950. The main contrast is
between birth cohorts in Quadrant A and Quadrant D. A second, albeit weaker, contrast is
between birth cohorts in Quadrants C and D. This classification is a crude tool but offers
us some leverage to identify birth cohorts with higher (lower) ‘propensity’ to experience
the imprints of delayed effects.
Figure 2: Classification of birth cohorts by year of birth and country’s year of
onset of mortality decline (axis not to scale)
Year of cohort's birth
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6. Materials, models, and methods
6.1 Data
We use the Latin American Mortality Database, LAMBdA (http://www.ssc.wisc.edu/
cdha/latinmortality), which documents the history of mortality in LAC countries after
independence. The data is for the period between 1848 and 2014 and contains about 500
life tables. The information to compute life tables for the period 1930–2010 are age-
specific death rates adjusted for relative completeness of death registration as well as for
adult-age overstatement. These life tables are available yearly. Life tables for most coun-
tries before 1930 are based on the application of generalized stable population to partial
vital statistics and census information. Yearly life tables for the period before 1950 are
available for a handful of countries only (N = 10). In all other cases we estimate life
tables every five or ten years. To fill in yearly missing data before 1930, we use splines
with three and four knots fitted to single age-specific mortality rates. Merging all the data
results in a set of calendar year and gender-specific (period) life tables in single-year ages
for the period 1870–2010. Cohort life tables, starting with those born in 1900, are com-
puted by chaining together age-specific rates of period life tables. Life tables for birth
cohorts born after 1900 contain variable right censoring of mortality experiences: If we
close the life tables with the open age group 85+, there is no censoring for birth cohorts
born before 1925 and maximum censoring among birth cohorts born after 1965 whose
adult mortality experience is truncated at age 45. To graphically represent birth cohorts
and the adult experience included in our analysis, Figure 3 shows a Lexis diagram of co-
horts’ life courses captured in this study. Cohorts born after 1965 offer minimal coverage
of adult mortality and are ignored. Cohorts born after 1940 and before 1965 are right
censored, and we only observe mortality up to some upper age limit, 70 to 75 for those
born in 1935 and 40 to 45 for those born in 1965. Limited observability of adult mortality
rate is, of course, an important limitation of our empirical analysis.
We also use the Human Mortality Database (HMD). We select five populations (Eng-
land and Wales, France, Italy, Norway, and Sweden) and perform placebo tests to gauge
the relative importance of delayed effects in the LAC region in contrast to populations of
Europe and North America.
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Figure 3: Lexis diagram depicting cohorts used in the study indicating adult
mortality in complete (darker section) and incomplete
(right-censored) cohorts and their corresponding cohort child
mortality
Year
Ag
e
1910
1915
1920
1925
1930
1935
1940
1945
1950
1955
1960
1965
1970
1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Co
ho
rt
co
ho
rts
 ign
ore
d
co
ho
rts
 rig
ht−
cen
sor
ed
Cohorts
born after 1935
Cohorts
born before 1935
6.2 Models and methods
Prediction 1
One way to test Prediction 1, is to contrast rates of change of mortality rates for successive
births cohorts at selected adult ages (40–59, 40–64, and 40–69). We expect that the rate
of decline in countries most susceptible to experience delayed effects will decline for
younger cohorts, particularly among those born after 1935. By the same token, birth
cohorts born after 1935 or so should experience stronger deceleration than cohorts born
before 1935.
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Prediction 2.1
To test the prediction 2.1, we first estimate parameters of the relation between changes
in cohorts’ child mortality at young ages and changes in their adult mortality. Graphs
of these relations are in Figure S-1 in Supplemental Material I. We use two approaches:
First, we estimate a linear regression model for the log of cohorts’ adult mortality rates at
ages (x,x+ k), Mi(x, t), as a function of the log of their child mortality rates (ages 0 to
4), Mi(0, t):
ln(Mi(x, t)) = αi + βi ∗ ln(Mi(0, t)) + i (1a)
where t is the calendar year of birth of the cohort and i is an index for country. The
regression coefficient β is the proportionate change in adult mortality of a cohort given a
unit-proportionate change in its child mortality. In populations with a secular mortality
decline where changes are proportionate at all ages, the value of β should be identical
for all cohorts. Differences across populations will reflect heterogeneity in the pace of
mortality decline. However, when there are delayed effects for some cohorts but not for
others, the regime in Equation (1a) will systematically differ across cohorts (and popula-
tions). In particular, we expect that estimates of β should be lower in cohorts primed to
express delayed effects. To verify that this is the case, we estimate country-specific pa-
rameters of model 1a for three adult age groups (40–59, 40–64, and 40–69), and we do so
separately for cohorts born before and after the year 1935. Prediction 2.1 points to strong
contrasts between estimates of the slope parameter in the younger and older cohorts, on
one hand, and in forerunner and laggard countries, on the other.
We use a second approach that consists of estimating a similar model to Equation
(1a) using a mixed model framework (multilevel). Models are estimated separately by
age group, sex, and stage of demographic transition (e.g., forerunner and laggard):
Level 1:
ln(Mij(x, t)) = a0j + β1j ln(Mij(0, t)) + rij (1b)
Level 2:
a0j = γ00 + γ01(Born after 1935) + u0j
β1j = γ10 + γ11(Born after 1935) + u1j
where: i is cohort and j is country, rij is a normally distributed error with homogeneous
variance across countries, a0j and β1j vary across countries in level-2, γ00 represents the
mean log mortality rate for cohorts born before 1935, γ01 represents the difference in the
mean log mortality rate between cohorts born before and after 1935, γ10 represents the
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mean proportionate change in adult mortality for cohorts born before 1935 given a unit-
proportionate change in child mortality, and γ11 represents the difference in the mean
proportionate change in adult mortality between cohorts born before and after 1935 given
a unit-proportionate change in child mortality, u0j and u1j are multivariate normally dis-
tributed with means of zero and conditional variance-covariance components after con-
trolling for cohort’s year of birth; in other words, they represent residual dispersion in a0j
and β1j after controlling for cohort’s year of birth.
Of particular importance for prediction 2.1 is the parameter γ11, a measure of differ-
ences in proportionate changes in adult mortality between cohorts.
Prediction 2.2
To falsify prediction 2.2, we implement two tests. The first rests on estimation of the
following model:
ln(GSi(t)) = λi + θi ∗ ln(Mi(0, t)) + σi (2)
where GSi(t) and Mi(0, t) are, respectively, the Gompertz slope and child mortality rates
for a cohort born in year t in population in country i. Model 2 is estimated for each
country and separately for cohorts born before and after 1935. Prediction 2.2 suggests
that estimates of the slope in model 2 will be attenuated in more recently born cohorts,
particularly in laggard countries.
The second test depends on the following consideration: Suppose we do indeed ob-
serve a reduction in slopes in model 2 in LAC countries. It may be the case that such
reduction is induced by conditions other than by the presence of delayed effects, perhaps
related to factors that drive most secular mortality declines, and are omitted from the
model. If this were the case we should observe a similar pattern in populations that also
undergo secular mortality declines but where we do not expect delayed effects to be influ-
ential. Most countries in Western Europe experienced a mortality decline with an onset
circa 1850, long before the introduction of medical technology. It was gradual and driven
by changes in sanitation, housing, and – most importantly – improvements in nutritional
status. In these cases, we would expect that estimates of model 2 reveal similar shifts
to those observed in LAC but only because they are the result of other features of a sec-
ular mortality decline, not the consequence of delayed effects. Otherwise, the relations
estimated for birth cohorts in these European populations should yield higher predicted
values of GS(t) for cohorts experiencing a given value of M(0, t) than do parameter esti-
mates in LAC for cohorts with identical values of M(0, t). The placebo test consists then
of computing values of GSi(t) in LAC birth cohorts predicted from model 2 but with
parameters estimated in countries of Northern and Western Europe. To carry out this test,
we estimate model 2 using mortality data for the five HMD countries mentioned before.
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Table 2: Number of cases where the rate of change of age specific mortality
rates for a cohort are lower than for the preceding cohort
(deceleration) for ages 40–59, 40–64, and 40–69
Female
Born before 1935 Born after 1935
Deceleration n % Deceleration n %
Forerunners
40–59 143 273 52.38 71 135 52.59
40–64 130 273 47.62 53 90 58.89
40–69 128 273 46.89 24 45 53.33
Laggards
40–59 60 126 47.62 51 88 57.95
40–64 68 126 53.97 37 56 66.07
40–69 64 126 50.79 17 26 65.38
Male
Born before 1935 Born after 1935
Deceleration n % Deceleration n %
Forerunners
40–59 140 273 51.28 77 135 57.04
40–64 131 273 47.99 51 90 56.67
40–69 134 273 49.08 30 45 66.67
Laggards
40–59 70 126 55.56 43 88 48.86
40–64 63 126 50.00 35 56 62.50
40–69 63 126 50.00 15 26 57.69
7. Results
Prediction 1
We test Prediction 1 using rates of change of mortality rates for successive births cohorts
at adult ages (40–59, 40–64, and 40–69). Table 2 displays the frequency of cases that
agree with the prediction (that is cases where the rate of change of age-specific mortality
rates at adult ages for a birth cohort are lower than for the preceding cohort). With one
exception, (males at ages 40–59), birth cohorts born after 1935 exhibit stronger deceler-
ation in the rates of change of mortality rates than those born before 1935. In addition,
the magnitude of deceleration in cohorts born in laggard countries is larger than observed
in forerunners. For example, in about two-thirds (66%) of cases corresponding to female
birth cohorts born after 1935 experienced deceleration of the rate of change of mortality
rates at ages 40–64. The figure for those born before 1935 is 54%. Moreover, and as
expected, the fraction of cases that conform with the prediction increases with age. For
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example, a comparison of changes in mortality rates in the age group 40–64 against those
in the age group 40–59, consistently reveals a higher fraction of cases with deceleration
in cohorts born after 1935. In addition, the observed differences are larger in cohorts
born after 1935. These patterns are less consistent for the age group 40–69, but the num-
ber of uncensored birth cohorts that enter into the calculations is, in this case, quite low
and comparisons accordingly noisier. In sum, although the statistical power of the test is
admittedly modest, the observed patterns agree with all expectations.
Prediction 2.1
According to prediction 2.1 the regression coefficients of model 1a are expected to be of
lower magnitude for the more recently born cohorts and for populations more likely to
express delayed effects. Similarly, γ11 in model 1b is expected to be negative – implying
lower magnitude among recently born cohorts. To estimate models 1a and 1b while
maintaining acceptable sample sizes, we choose adult age groups 40–59, 40–64, and 40–
69. This choice is not optimal to assess the full-blown impact on adult mortality since,
due to right censoring of cohorts’ mortality experiences, we only capture effects in the
youngest part of their adult life, when morbidity and mortality risks are less severe. If the
model is correct, this choice of age groups will lead to understate the effects of interest.
Table 3 displays estimates of model 1 using the adult age group 40–64. Similar
inferences can be drawn from results for age groups 40–59 and 40–69 included in Tables
S-1 in Supplemental Material I. Table 4 displays estimates of the multilevel model, for
age group 40–64; similar inferences can be drawn from results for age groups 40–59
and 40–69 in Tables S-2 in Supplemental Material I. Figure 4 is a box plot of estimated
regression coefficients for the age group 40–64 by sex, type of country, and timing of
the cohorts’ birth (see Figures S-2 in Supplement Material I for box plots of coefficients
using other age groups).
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Figure 4: Box plots of estimated coefficients of the regression
ln(Mi(40, 64)) = αi + βi ∗ ln(Mi(0, 4)) + i by country (i), sex, and
cohort year of birth; M(40, 64) and M(0, 4) correspond to cohort
mortality rates at ages 40–64 and 0–4
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With one exception (Cuban males born after 1935) the estimates in Table 3 are all
positive confirming a finding in high income countries, namely, that a cohort’s relative
gains (losses) in early child survival tend to be preserved or augmented at older adult
ages (Finch and Crimmins 2004). Furthermore, with two exceptions (males in Argentina
and Uruguay), the magnitude of the regression coefficients for the more recent cohorts
(born after 1935) declines over time as expected and, in some cases, substantially so.
Results from model 1b in Table 4 provide additional supporting evidence as they confirm
a statistically significant decline in the regression coefficients for cohorts born after 1935
with larger reductions among cohorts in laggard countries.
What practical implications does the generalized decrease in slopes among younger
birth cohorts have? An appealing interpretation is the following: Since the slope in model
1a is an estimate of the expected change in a birth cohort’s adult mortality conditional on
the cohort’s change in child mortality, we can translate (approximately) the estimate of
the slope into gains in years of life expectancy at age 60 implied by the cohort’s child mor-
tality changes. Cohorts endowed with smaller slopes are expected to experience smaller
gains in life expectancy at age 60 than cohorts with higher slopes for a given change in
their child mortality. In other words, birth cohorts exposed to delayed effects that reduce
the magnitude of the slopes will experience ‘foregone’ gains of life expectancy at age 60.
The formal justification for this computation and the expressions used to generate esti-
mates and 95% CI’s are in the Appendix 2. Table 5 displays proportionate years of life
expectancy at age 60 that cohorts born before and after 1935 would gain over a period of
20 years given a decline of 1% per year in their child mortality (Columns 1 and 2). Col-
umn 3 displays the ratios of values for the younger (Column 2) to the older (Column 1),
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Column 4 shows the 95% CI (approximates), Column 5 displays years of life expectancy
gains foregone, and Column 6 includes the corresponding 95% CI (approximated). For
example, in Peru the ratio for males is 0.68 (1.361/2.002), indicating that the younger
cohorts experience gains in life expectancy at age 60 about 68% as large as the gains in
the older cohorts given identical changes in early childhood mortality rates. Figure 5 is a
box plot of estimated years of life expectancy at age 60 foregone among younger cohorts
(Column 5 of Table 5) by cohort, sex, and type of country. To place these quantities in
perspective, consider the following: The average LAC’s female life expectancy at age 60
in the year 2000 was of the order of 18 years and, according to projections, it is expected
to increase to about 21 years in the year 2020, a gain of about 3 years (17%) (United Na-
tions 2017). The more recent female birth cohorts in Peru would only gain approximately
1.92 of these three years or, equivalently, would experience 1.08 years of gains of the
projected total (Table 5, column 5). This is about 6% of the baseline life expectancy at
age 60 in the year 2000. It is worth noting that the order of magnitude of these estimates
is somewhat lower than estimates of mortality penalties associated with delayed effects
obtained with completely different procedures by other researchers (Palloni and Souza
2013).
Figure 5: Box plots of estimated years of life expectancy at age 60 foregone for
cohorts born after 1935
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There are two problems with this evidence. The first is that prediction 2.1 is not
perfectly satisfied. According to this prediction, birth cohorts in countries whose mor-
tality decline started earlier should manifest the expected pattern – discordance of gains
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between older and younger cohorts – more weakly than do birth cohorts in laggard coun-
tries. However, the results from the multilevel model corroborate this expectation as the
parameter γ11 is always smaller in forerunner countries except in a few cases for the age
group 60–69. Also, the years of life expectancy gain foregone by younger cohorts are
indeed larger in laggard countries even though males appear to be more affected than
females (Figure 5).
The second, and deeper, problem is one of interpretation: While the observed dis-
cordance between older and younger birth cohorts could be a result of delayed effects,
other mechanisms may also account for the finding. We return to this issue latter in the
paper.
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Table 3: Estimated coefficients of the regression
ln(Mi(40, 64)) = αi + βi ∗ ln(Mi(0, 4)) + i by country (i), sex, and
cohort year of birth. M(40, 64) and M(0, 4) correspond to cohort
mortality rates at ages 40–64 and 0–4
Female aged 40–64
Born before 1935 Born after 1935
n β SE 95% CI R2 n β SE 95% CI R2
Forerunners
Argentina 35 0.76 0.031 (0.7,0.82) 0.95 12 0.22 0.011 (0.2,0.24) 0.97
Chile 35 2.71 0.093 (2.53,2.89) 0.96 12 0.77 0.033 (0.71,0.84) 0.98
Colombia 30 1.64 0.055 (1.53,1.74) 0.97 12 1.29 0.037 (1.22,1.36) 0.99
Costa Rica 35 2.00 0.080 (1.84,2.16) 0.95 12 0.73 0.020 (0.69,0.77) 0.99
Cuba 35 1.02 0.114 (0.79,1.24) 0.71 12 0.18 0.010 (0.16,0.2) 0.97
Mexico 35 2.17 0.116 (1.94,2.39) 0.91 12 0.70 0.032 (0.64,0.76) 0.98
Panama 24 1.45 0.046 (1.36,1.54) 0.98 12 0.69 0.024 (0.64,0.74) 0.99
Uruguay 35 0.51 0.017 (0.48,0.54) 0.97 12 0.15 0.038 (0.08,0.23) 0.61
Venezuela 9 0.51 0.025 (0.46,0.56) 0.98 12 0.49 0.028 (0.43,0.54) 0.97
Laggards
Brazil 35 3.51 0.087 (3.34,3.68) 0.98 12 1.80 0.058 (1.69,1.92) 0.99
Dominican Republic 15 1.72 0.066 (1.59,1.85) 0.98 12 1.46 0.051 (1.36,1.56) 0.99
El Salvador 6 0.97 0.067 (0.84,1.1) 0.98 11 0.52 0.040 (0.44,0.59) 0.95
Guatemala 35 3.22 0.137 (2.96,3.49) 0.94 11 1.34 0.084 (1.17,1.5) 0.97
Nicaragua 11 0.17 0.070 (0.03,0.31) 0.39
Peru 35 3.47 0.096 (3.28,3.66) 0.98 11 1.54 0.039 (1.46,1.61) 0.99
Male aged 40–64
Born before 1935 Born after 1935
n β SE 95% CI R2 n β SE 95% CI R2
Forerunners
Argentina 35 0.40 0.012 (0.38,0.42) 0.97 12 0.43 0.010 (0.41,0.45) 0.99
Chile 35 2.00 0.056 (1.89,2.11) 0.98 12 0.82 0.031 (0.76,0.89) 0.99
Colombia 30 1.36 0.062 (1.24,1.48) 0.95 12 0.63 0.052 (0.53,0.73) 0.94
Costa Rica 35 1.45 0.112 (1.23,1.67) 0.83 12 0.54 0.053 (0.44,0.65) 0.91
Cuba 35 1.06 0.125 (0.81,1.3) 0.68 12 –0.09 0.038 (–0.17,–0.02) 0.36
Mexico 35 1.60 0.091 (1.42,1.78) 0.90 12 0.74 0.023 (0.69,0.78) 0.99
Panama 24 1.13 0.032 (1.07,1.2) 0.98 12 0.25 0.020 (0.21,0.28) 0.94
Uruguay 35 0.30 0.014 (0.28,0.33) 0.94 12 0.31 0.031 (0.25,0.37) 0.91
Venezuela 9 0.45 0.032 (0.39,0.52) 0.97 12 0.28 0.027 (0.22,0.33) 0.91
Laggards
Brazil 35 2.43 0.056 (2.32,2.54) 0.98 12 1.45 0.039 (1.37,1.53) 0.99
Dominican Republic 15 0.86 0.103 (0.66,1.06) 0.84 12 0.53 0.044 (0.45,0.62) 0.94
El Salvador 6 0.43 0.053 (0.32,0.53) 0.94 11 0.61 0.070 (0.48,0.75) 0.89
Guatemala 35 2.34 0.117 (2.11,2.57) 0.92 11 1.44 0.057 (1.32,1.55) 0.99
Nicaragua 11 0.19 0.057 (0.07,0.3) 0.54
Peru 35 3.60 0.128 (3.35,3.85) 0.96 11 1.34 0.035 (1.28,1.41) 0.99
Note: Coefficients were estimated only when more than five cohorts were available.
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Table 4: Estimated regression coefficients from a linear mixed model of the log
of adult cohort mortality as a function of childhood mortality fitted
separately by sex and country’s state of demographic transition for
ages 40–64
Females aged 40–64
Forerunner Laggard
Model Unconditional Conditional on Unconditional Conditional on
components year of birth year of birth
(a) (b) (a) (b)
Fixed effects
Model for intercept
γ^00 –0.674*** –0.205 0.438 1.269**
γ^01 = Born after 1935 –0.972*** –1.522***
Model for slope
γ^10 1.009*** 1.418*** 1.785*** 2.599***
γ^11 = Born after 1935 –0.840** –1.483**
Random effects: Variance Variance Variance Variance
Intercept 0.606*** 0.387*** 1.645*** 1.109***
Slope 0.513*** 0.351*** 1.328*** 0.790***
Percent of the variance explained in parameters by adding year of birth
Intercept – 36.198 – 32.572
Slope – 31.548 – 40.535
Males aged 40–64
Forerunner Laggard
Model Unconditional Conditional on Unconditional Conditional on
components year of birth year of birth
(a) (b) (a) (b)
Fixed effects
Model for intercept
γ^00 –0.548*** –0.215 0.252 0.779*
γ^01 = Born after 1935 –0.693*** –0.974***
Model for slope
γ^10 0.762*** 1.089*** 1.389*** 1.964***
γ^11 = Born after 1935 –0.671** –1.058
Random effects: Variance Variance Variance Variance
Intercept 0.336*** 0.225*** 0.845*** 0.645***
Slope 0.310*** 0.205*** 1.074*** 0.843***
Percent of the variance explained in parameters by addding year of birth
Intercept – 33.014 – 23.723
Slope – 33.876 – 21.535
Note: Level 1: ln(Mi j (x , t)) = a0j + β1j ln(Mi j (0, t)) + ri j ;
Level 2: a0j = γ00 + γ01(Born after 1935) + u0j ;
β1j = γ10 + γ11(Born after 1935) + u1j .∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05. See text for a full description of the model parameters.
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Table 5: Years of gains in life expectancy gained and foregone at age 60 and
approximate 95% CI with bootstrap computations
Female
Proportionate gains ratios Years gains foregone
(1) (2) (3) (4) (5) (6)
Born before Born after (2)/(1) 95% CI for (3) Born after 95% CI
1935 1935 1935
Forerunners
Argentina 1.083 1.090 1.006 (1,1.012) 0.686 (0.682,0.69)
Chile 1.492 1.178 0.790 (0.764,0.815) 0.874 (0.856,0.891)
Colombia 1.313 1.134 0.864 (0.832,0.897) 0.798 (0.776,0.821)
Costa Rica 1.336 1.114 0.834 (0.784,0.883) 0.828 (0.794,0.862)
Cuba 1.236 0.982 0.795 (0.742,0.847) 0.868 (0.832,0.904)
Mexico 1.377 1.015 0.737 (0.699,0.775) 0.936 (0.91,0.962)
Panama 1.254 1.051 0.839 (0.824,0.854) 0.823 (0.812,0.833)
Uruguay 1.062 1.064 1.002 (0.988,1.016) 0.689 (0.679,0.698)
Venezuela 1.094 1.058 0.967 (0.95,0.983) 0.714 (0.702,0.725)
Laggards
Brazil 1.626 1.336 0.822 (0.795,0.849) 0.839 (0.821,0.858)
Dominican Rep. 1.188 1.112 0.936 (0.891,0.981) 0.737 (0.706,0.768)
El Salvador 1.090 1.130 1.037 (1.002,1.072) 0.666 (0.641,0.69)
Guatemala 1.597 1.334 0.835 (0.783,0.887) 0.826 (0.79,0.862)
Peru 2.054 1.307 0.636 (0.583,0.689) 1.084 (1.048,1.121)
Male
Proportionate gains ratios Years gains foregone
(1) (2) (3) (4) (5) (6)
Born before Born after (2)/(1) 95% CI for (3) Born after 95% CI
1935 1935 1935
Forerunners
Argentina 1.164 1.045 0.898 (0.884,0.911) 0.769 (0.76,0.778)
Chile 1.719 1.166 0.678 (0.639,0.718) 1.017 (0.99,1.044)
Colombia 1.388 1.294 0.932 (0.906,0.959) 0.740 (0.722,0.758)
Costa Rica 1.492 1.157 0.776 (0.743,0.809) 0.890 (0.867,0.912)
Cuba 1.226 1.037 0.845 (0.8,0.891) 0.816 (0.785,0.848)
Mexico 1.543 1.150 0.745 (0.697,0.793) 0.926 (0.893,0.959)
Panama 1.336 1.148 0.859 (0.838,0.88) 0.803 (0.789,0.818)
Uruguay 1.107 1.030 0.931 (0.914,0.947) 0.742 (0.73,0.753)
Venezuela 1.107 1.103 0.996 (0.981,1.011) 0.693 (0.682,0.703)
Laggards
Brazil 2.018 1.433 0.710 (0.669,0.752) 0.971 (0.942,1)
Dominican Rep. 1.411 1.339 0.949 (0.916,0.983) 0.727 (0.704,0.75)
El Salvador 1.214 1.110 0.914 (0.883,0.945) 0.755 (0.733,0.777)
Guatemala 1.904 1.307 0.687 (0.622,0.751) 1.005 (0.961,1.049)
Peru 2.002 1.361 0.680 (0.638,0.721) 1.015 (0.986,1.044)
Note: Columns 1 and 2 are for proportionate gains in life expectancy at age 60 associated with a 1% decline in child
mortality in cohorts born before and after 1935. Column 3 is for the ratios of proportionate gains of cohorts born
before and after 1935. Column 4 is for the 95% confidence intervals of estimates in column 3 (approximated using
delta method; see Appendix 2). Column 5 is for the number of years of life expectancy at age 60 foregone by the
cohorts born after 1935. Column 6 is for the 95% confidence interval of quantities in column 6 (approximated using
delta method; see Appendix 2).
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Prediction 2.2
Prediction 2.2 is about the within-cohort relation between early childhood mortality and
the slope of adult mortality rates. According to this prediction, we expect that more
recent birth cohorts, those most vulnerable to the influence of delayed effects, should
experience downward shifts in the adult mortality slope conditional on their childhood
mortality experiences. A corollary leads to a placebo-type test: The rate of senescence in
birth cohorts highly primed for the expression of delayed effects should be smaller than
expected in populations that are less primed to express delayed effects.
To implement the test, we rely on mortality patterns in five European countries in-
cluded in the Human Mortality Database, estimate model 2, and then use these estimates
to predict expected Gompertz slopes in each of the birth cohorts in LAC, given their lev-
els of child mortality. The expectation is that the predicted slope will be larger than the
observed one. Global prediction 2.2 is that differences between predicted and observed
values will be larger for cohorts born after 1935 and in countries with a mortality decline
that was faster, later, and more dependent on medical technology.
Figures S-3 in the supplement I are plots of the secular relation between child mor-
tality and Gompertz slopes in LAC and the HMD countries. To test for sensitivity to right
censoring of cohorts, each of the three figures employs a different set of adult age groups
to compute the slope (40–59, 40–64, and 40–69). Table 6 displays a full set of statistics
for Model 2 in LAC from regressions that use Gompertz slopes estimated with age group
40–64. Similar inferences follow from results for age groups 40–59 and 40–69 in Tables
S-3 and in Figures S-4 in Supplemental Material I. The panel for LAC shows that coeffi-
cients are equally likely to be negative or positive. In contrast, in all five HMD countries
the slopes are negative, and birth cohorts that experience lower risks of child mortality
also experience more accelerated aging. The negative association between early life mor-
tality and Gompertz slopes is consistent with previous evidence from European cohorts
born in both the 19th century and the early 20th century (Beltra´n-Sa´nchez, Crimmins, and
Finch 2012). A comparison of cohorts born before and after 1935 in LAC suggests that in
all but three of 14 possible contrasts, the slopes are, as expected by prediction 2.2, attenu-
ated and substantially so, with reduction ratios ranging from about 1.1 to 4.5 in males and
females alike. However, the magnitude of the attenuation is somewhat larger in forerun-
ner than in laggard countries, a finding inconsistent with global prediction 2.2. Although
the comparison between the two periods is less meaningful in the European context, it is
interesting to note that there the relation between early mortality and senescence sharpens
over time – becoming more negative – rather than attenuating as it does in LAC.
The placebo test requires computation of expected Gompertz slopes in cohorts born
in LAC using the relations observed in the European countries. Table 7 displays pro-
portionate differences between predicted (from an equation estimated for Sweden) and
observed values of Gompertz slopes for cohorts born before and after 1935 using all
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three age groups. Figure 6 plots predicted versus observed values of Gompertz slopes
using relations estimated in all five HMD countries, whereas Figure 7 contains box plots
of the magnitude of proportionate differences for ages 40–59, 40–64, and 40–69.8
While not perfect, the agreement with prediction 2.2 is quite strong. First, pro-
portionate differences tend to increase in absolute values in more than 90% of the birth
cohorts, irrespective of the age group contributing to estimates of Gompertz slopes. In
countries where the oldest cohorts are characterized by negative values, the younger co-
horts become associated with less negative or positive differences. And in countries where
the older birth cohorts are characterized by positive differences, the younger cohorts be-
come associated with much larger positive values. Thus, there seems to be a strong push
toward an increase in the difference between what would be expected under the Swedish
mortality regime and what is observed, just as prediction 2.2 would have it. Second,
differences for the cohorts born more recently tend to be higher in laggard than in fore-
runner countries. Thus, all five countries with the lowest differences are forerunners and
only three of them (Chile, Colombia, and Mexico) display values larger than at most two
laggard countries (Mexico). This is consistent with global prediction 2.2.
Finally, Figure 6 reveals two additional features in the placebo test. First, differences
between predicted and observed Gompertz slopes behave similarly, irrespective of which
HMD country we choose as benchmark. Second, the contrasts produced when using
different adult age groups to compute Gompertz slopes are reasonably concordant and
lead to similar inferences (see also Table 7).
8 We compute predicted Gompertz’s slopes for all LAC cohorts, irrespective of whether or not their child
mortality is within the range of observed values in HMD countries. This is unlikely to distort comparisons as
it affects a few cohorts in LAC born after 1935 whose child mortality was experienced by countries in HMD
before 1935.
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Figure 6: Predicted and observed Gompertz slopes for cohorts born before and
after 1935. Predicted Gompertz-slopes in LAMBdA are computed
from Equation (2) for HMD cohorts born before and after 1935
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Figure 7: Box plots of proportionate differences (x100) between predicted and
observed Gompertz slopes
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Note: Proportionate difference is computed as 100*(predicted slope – observed slope)/observed slope.
1194 http://www.demographic-research.org
Demographic Research: Volume 40, Article 41
Table 6: Estimated regression coefficients of the regression
ln(GSi(40, 64)) = λi + θi ∗ ln(Mi(0, 4)) + σi by country (i), sex, and
cohort year of birth; GS(40, 64) stands for Gompertz-slope between
ages 40–64; M(0, 4) corresponds to cohort mortality rate at age 0–4
Female aged 40–64
Born before 1935 Born after 1935
n θ SE 95% CI R2 n θ SE 95% CI R2
Forerunners
Argentina 35 –0.93 0.172 (–1.26,–0.59) 0.47 12 –0.46 0.016 (–0.49,–0.43) 0.99
Chile 35 –0.59 0.170 (–0.92,–0.25) 0.26 12 –0.59 0.064 (–0.71,–0.46) 0.90
Colombia 30 –0.88 0.073 (–1.03,–0.74) 0.84 12 0.45 0.073 (0.31,0.59) 0.79
Costa Rica 35 –1.56 0.110 (–1.77,–1.34) 0.86 12 –0.04 0.106 (–0.25,0.16) 0.02
Cuba 35 –1.14 0.096 (–1.33,–0.95) 0.81 12 0.32 0.028 (0.26,0.37) 0.93
Mexico 35 –1.71 0.119 (–1.95,–1.48) 0.86 12 –0.95 0.030 (–1.01,–0.89) 0.99
Panama 24 –0.02 0.105 (–0.23,0.18) 0.00 12 –0.58 0.064 (–0.71,–0.46) 0.89
Uruguay 35 –0.25 0.039 (–0.33,–0.17) 0.55 12 –0.04 0.043 (–0.13,0.04) 0.10
Venezuela 9 –0.49 0.030 (–0.55,–0.43) 0.97 12 0.00 0.007 (–0.01,0.02) 0.04
Laggards
Brazil 35 3.10 0.214 (2.68,3.52) 0.86 12 –1.46 0.116 (–1.68,–1.23) 0.94
Dominican Republic 15 1.13 0.363 (0.42,1.84) 0.43 12 –1.72 0.097 (–1.91,–1.53) 0.97
El Salvador 6 –0.50 0.083 (–0.66,–0.34) 0.90 11 –0.62 0.055 (–0.73,–0.52) 0.94
Guatemala 35 –0.63 0.202 (–1.03,–0.23) 0.23 11 –1.05 0.155 (–1.36,–0.75) 0.84
Nicaragua 11 –0.48 0.088 (–0.65,–0.3) 0.76
Peru 35 –1.93 0.391 (–2.7,–1.17) 0.43 11 –0.24 0.244 (–0.72,0.24) 0.10
Male aged 40–64
Born before 1935 Born after 1935
n θ SE 95% CI R2 n θ SE 95% CI R2
Forerunners
Argentina 35 –0.22 0.117 (–0.45,0.01) 0.10 12 –0.23 0.032 (–0.29,–0.17) 0.84
Chile 35 0.25 0.127 (0,0.5) 0.11 12 –0.65 0.037 (–0.72,–0.57) 0.97
Colombia 30 –0.45 0.076 (–0.6,–0.31) 0.56 12 1.30 0.094 (1.12,1.48) 0.95
Costa Rica 35 –1.36 0.225 (–1.8,–0.91) 0.52 12 –0.19 0.072 (–0.33,–0.05) 0.40
Cuba 35 –0.71 0.069 (–0.84,–0.57) 0.76 12 0.22 0.036 (0.15,0.29) 0.79
Mexico 35 –0.87 0.128 (–1.12,–0.62) 0.59 12 –0.71 0.057 (–0.82,–0.6) 0.94
Panama 24 0.02 0.061 (–0.1,0.14) 0.00 12 –0.60 0.050 (–0.7,–0.51) 0.94
Uruguay 35 –0.16 0.045 (–0.25,–0.07) 0.28 12 –0.01 0.047 (–0.1,0.08) 0.01
Venezuela 9 0.28 0.028 (0.22,0.33) 0.93 12 –0.09 0.034 (–0.16,–0.02) 0.40
Laggards
Brazil 35 1.41 0.120 (1.17,1.64) 0.81 12 0.23 0.058 (0.12,0.35) 0.62
Dominican Republic 15 0.35 0.074 (0.2,0.49) 0.63 12 0.01 0.078 (–0.15,0.16) 0.00
El Salvador 6 2.06 0.330 (1.41,2.7) 0.91 11 –1.47 0.520 (–2.49,–0.45) 0.47
Guatemala 35 –1.23 0.160 (–1.54,–0.91) 0.64 11 0.28 0.594 (–0.89,1.44) 0.02
Nicaragua 11 –0.45 0.195 (–0.83,–0.07) 0.38
Peru 35 –1.86 0.310 (–2.47,–1.25) 0.52 11 1.01 0.198 (0.62,1.4) 0.74
Note: A Gompertz-slope is separately estimated for each country-cohort-sex from the modelM(x) = a∗exp(b∗x),
for x  [40, 64]. Coefficients were estimated only when more than five cohorts were available.
http://www.demographic-research.org 1195
Verhulst, Beltra´n-Sa´nchez & Palloni: Impact of delayed effects on human old-age mortality
Table 7: Proportionate differences between predicted (counterfactual) and
observed values of birth cohorts’ Gompertz slopes for ages 40–59,
40–64, and 40–69
Female
40–59 40–64 40–69
Prop. Prop. Prop.
Country Diff. Country Diff. (%) Country Diff. (%)
Peru 24.18 Peru 23.35 Peru 19.32
Mexico 15.50 Mexico 13.62 Mexico 15.52
Guatemala 0.59 Guatemala 7.35 Guatemala 9.38
Costa Rica –7.31 El Salvador –1.08 El Salvador 7.93
Chile –16.43 Costa Rica –9.19 Chile –4.35
El Salvador –21.98 Chile –10.02 Dom. Rep. –6.61
Colombia –23.56 Dom. Rep. –15.10 Brazil –7.54
Dom. Rep. –25.21 Brazil –16.33 Costa Rica –9.91
Brazil –29.04 Colombia –18.50 Colombia –13.52
Panama –31.22 Panama –24.25 Panama –16.71
Uruguay –35.00 Uruguay –27.06 Argentina –23.46
Argentina –38.29 Argentina –30.08 Uruguay –23.84
Cuba –42.11 Cuba –35.35 Venezuela –27.76
Venezuela –45.13 Venezuela –35.87 Cuba –29.57
Male
40–59 40–64 40–69
Prop. Prop. Prop.
Country Diff. Country Diff. (%) Country Diff. (%)
El Salvador 124.02 El Salvador 107.22 El Salvador 83.85
Guatemala 114.73 Guatemala 74.73 Guatemala 64.93
Colombia 72.84 Colombia 37.38 Mexico 26.58
Ecuador 66.47 Nicaragua 36.29 Brazil 25.60
Mexico 42.18 Mexico 36.19 Nicaragua 18.94
Nicaragua 42.01 Brazil 34.90 Chile 17.02
Brazil 37.53 Peru 27.30 Colombia 14.90
Chile 30.93 Chile 27.03 Peru 13.31
Peru 30.90 Dom. Rep. 20.82 Panama 4.15
Dom. Rep. 28.54 Panama 15.70 Argentina –6.22
Panama 13.46 Venezuela 0.33 Costa Rica –7.33
Venezuela 3.71 Argentina –4.44 Uruguay –12.65
Costa Rica –3.40 Costa Rica –4.99 Cuba –13.92
Argentina –4.73 Cuba –8.48
Cuba –6.57 Uruguay –12.01
Paraguay –7.98
Uruguay –13.47
Note: Proportionate difference is computed as 100*(predicted slope – observed slope)/observed slope.
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8. Summary of findings, limitations, and the road ahead
The implications of DOHaD conjectures for aggregate population patterns of human dis-
ease, disability, mortality, and aging are poorly understood. In this paper we scratch the
surface of what could be a much larger field of research as we only investigate relations
involving mortality and ignore morbidity and disability. This is our first effort to sort out
consequences of DOHaD for aggregate population patterns and, as such, it has strengths
and weaknesses.
8.1 Summary of results
We employ a model of relations between early conditions and delayed effects to formu-
late two predictions that apply to aggregate adult mortality patterns in populations primed
for the expression of delayed effects. We define empirical conditions under which such
effects could be observed and test predictions with a long time series of cohort mortality
in LAC. A somewhat conservative conclusion from the empirical evidence we gathered
is that observed patterns are reasonably consistent with expectations from the model’s
predictions, and that LAC patterns of adult mortality do reveal the footprints that delayed
effects are predicted to leave on adult mortality patterns. Indeed, within bounds of un-
certainty we disclose explicitly, we find that more recently born cohorts experience both
deceleration in survival gains at older ages and distortions in their age patterns, including
reduction of the association between child mortality and adult mortality and the attenua-
tion of the rate of aging at older ages.
The empirical evidence we retrieved, however, is not water-tight, depends on param-
eter estimates that are somewhat fragile, and – importantly – can be accounted for with
alternative explanations. We address each of these issues below.
8.2 Limitations
Our analyses have several shortcomings. First, the model and predictions rest on the sim-
plifying assumption that all mechanisms invoked by variants of DOHaD induce delayed
effects that can be bundled together and studied jointly. This assumption is likely to be
incorrect, but it is not immediately clear how its violation could bias our estimates of total
or gross impacts.
Second, the empirical tests we rely on are based on fictitious, not real, cohort life
tables. This is unavoidable as there are no life tables for real cohorts in LAC and only
a handful (for birth cohorts born before 1925 in countries with registration systems) in
HMD. Construction of life tables for fictitious birth cohorts relies on chaining together
yearly mortality rates for single age groups. And while under ideal conditions these
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estimates closely approximate the mortality trajectory of a real cohort, there can be in-
consistencies. To ascertain that inconsistencies do not bias our results, we launched a
verification experiment using HMD. The results of this experiment, documented in Sup-
plementary Material II, confirm two regularities. First, life tables for real and fictitious
cohorts lead to estimates of mortality patterns that can be characterized by virtually the
same parameters and (b) the relation between those parameters in a life table for the real
cohort is closely matched by the same relation in the life table of the fictitious cohorts.
An added bonus from the experiment that came as a surprise to us is this: Estimates of
Gompertz slopes with censored cohorts (with mortality experiences between ages 40–
59, 40–64, and 40–69) are strongly correlated (R2 > .90) with Gompertz slopes using
uncensored mortality experiences (ages 40–90). Furthermore, the relations between es-
timates from uncensored adult mortality experiences and early mortality are reproduced
very closely by relations between censored adult experiences and child mortality.
Third, our empirical tests did not account for confounding that was a result of the in-
trusion of differential improvements in medical technologies that target chronic illnesses
related to delayed effects. If, for example, improvements in screening and treatment of
T2D – one of the key chronic illnesses associated with adverse early conditions – out-
paced improvements associated with chronic diseases that are not related to delayed ef-
fects, we would underestimate the importance of the latter and underplay their influence.
Fourth, the empirical tests rely on imperfect data. Due to right censoring of adult
mortality experiences in LAC region, we have limited statistical power to test null hy-
potheses because the number of birth cohorts available for analysis plunges precisely
during periods when the adult consequences of delayed effects are more likely to be felt.
Significant right censoring is also a limitation that precludes the use of powerful
analytic techniques, such as Age–Period–Cohort models, that support stronger inferences.
Fifth, the classification of countries relies on a blunt tool, namely, the combination
of an indicator of timing of mortality decline with a categorization of countries by past
mortality experiences. Strictly speaking, the distinction between forerunners and lag-
gards is one that should apply to subgroups or individuals within countries. But we are
working with countries and nations and do not have historical data for regions as, for
example, the European Fertility Study did. Admitting this weakness, however, should not
blind us to the fact that the two criteria we use (timing of introduction of modern medi-
cal technology and timing of onset of mortality decline) are unlikely to be off by much.
In fact, the year(s) of onset of full dissemination of antibiotics and vaccines cannot ex-
ceed 1935–1940. There might be heterogeneity within countries because the timing of
full dissemination varies, particularly in populations whose mortality decline begins after
1935–1940. But this heterogeneity is at worst modest. On the other hand, we know with
high precision when mortality began to decline in each country and, therefore, in this case
at least, we have full information. Using a simple classification of countries, rather than
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continuous variables, could generate noise, but it is highly improbable that it will cause
more extensive damage.
Finally, throughout, we ignored distortions that could be caused by changes in mor-
tality due to accidents and violence, causes of death that have a peculiar profile in LAC
countries. Mortality due to violence and accidents is concentrated among males in the
age interval 15–40 or so. Over the last ten to fifteen years, these causes have become
less important, except in countries like Mexico, Venezuela, and El Salvador. In what
ways can these trends affect our conclusions? First, road traffic accidents in Latin Amer-
ican disproportionally involve individuals who drive vehicles and are (or were up until
recently at least) a selected group, perhaps less exposed to deleterious conditions early in
life. A decrease in these deaths will swell the population that is less likely to have experi-
enced adverse early conditions, thus working against our hypothesis. On the other hand,
deaths due to violence disproportionally occur in subpopulations that are more likely to
have been exposed to poor early conditions, and a decline in these deaths will have the
opposite effect from that of deaths due to violence and will thus operate in favor of the
conjecture. The net result is uncertain, and to sort out the exact direction of the bias one
would need to use full information on causes of death.
8.3 Future research
Future research in this area could proceed along a number of avenues. First, in this paper
we explored only the implications for one outcome, mortality patterns, when it is clear
that both morbidity and disability and, therefore, healthy life expectancy, must be heavily
affected as well. Generalizations to include morbidity and disability will require different
formal models and information on health outcomes of diverse nature.
Second, an important area of study is the potentially aggravating impacts on adult
health outcomes of mismatches between prenatal and postnatal environments. This is a
significant piece of the puzzle, as described by the Predictive Adaptive Response (PAR)
variant of DOHaD. Ignoring it, as we did here, underplays the role of delayed effects,
especially in countries where delayed effects are expected to be largest.
Any future research on this problem will face an unavoidable obstacle, which we
may refer to as “Popper’s curse,” namely, failure to falsify the theory is not equivalent
to successful verification. Falsifying DOHaD conjectures can only produce evidence to
reject them, not to confirm them. Concordance between the two predictions and empir-
ical findings is not invoked here to argue the validity of a claim; it is only an indication
of absence of inconsistency rather than material proof of the adequacy of the theory. Be-
cause the empirical patterns we detect in LAC could be the result of mechanisms other
than those embedded in a regime of delayed effects, more robust falsification necessitates
different research strategies than the ones we followed here. One of them is analyses
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of full-information case studies of populations (in countries or regions) that underwent
contrasting experiences. These studies should cover all dimensions required for proper
tests of DET, including empirical indicators of mismatching and the nature of mortality
decline. A second research strategy is to pursue studies of adult illnesses and mortal-
ity patterns with multiple birth cohorts exposed to heterogeneous early experiences and
in populations with different regimes of secular mortality decline, including timing of
onset, nature of mortality determinants, and size of mismatching. Third, comparative
studies of older populations that include rich information about early conditions as well
as detailed information on chronic illnesses, disability, and mortality, and fielded in pop-
ulations with disparate epidemiological and mortality regimes, will offer a more robust
empirical platform to test the aggregate population implications of DET.
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Appendix 1: Key results from a formal model of delayed effects
In previous work (Palloni and Beltra´n-Sa´nchez 2016, 2017) we show that age patterns of
mortality in a regime that combines delayed effects and secular mortality decline can be
concisely described. In particular, rates of changes with age and time, as well as time
trends in the associations between indicators of mortality at different ages, are captured
with simple expressions.
We assume that the force of mortality at age y of the ith individual in a birth cohort
born t years after the onset of mortality decline is given by
µi(y, t) = µs(y)k(t)Eyt(δ,R) (1)
where µs(y) is a baseline mortality pattern shared by the entire population, k(t) =
exp(−γt)9 is a multiplier that expresses mortality of birth cohort t relative to the base-
line mortality pattern at t = 0, and Eyt(δ,R) is the expected value of a (strictly pos-
itive, continuously distributed) random trait δ for susceptibility to delayed effects with
relative mortality risks equal to R > 1. In what follows we will refer to µi(y, t) =
µs(y)k(t)Eyt(δ, R = 1) as the ‘background’ force of mortality, that is, the force of
mortality that would prevail if there were no delayed effects, e.g., R = 1. Three results
follow from (1).
1. Rate of mortality change over time and in adult ages
The instantaneous rate of change of adult mortality over time is:
∂ ln(µ¯(y, t))
∂t
=
∂ ln(k(t))
∂t
[1− k(t)Λ¯(y, t,R)(CVyt(δ,R))2] (2)
where µ¯(y, t) is the average (observed) mortality rate at age y for the birth cohort born t
years after the onset of mortality decline, Λ¯(y, t,R) is the integrated force of mortality up
to age y for the same cohort, and CVyt(δ,R) is the coefficient of variation of the random
susceptibility trait (δ) at age y for the birth cohort born t years after the mortality decline.
In addition, the instantaneous age-related rate of change of adult mortality is given
by
∂ ln(µ¯(y, t))
∂y
=
∂ ln(µs(y))
∂y
− µs(y)Λ¯(y, t)(CVyt(δ,R))2. (3)
Since k(t)Λ¯(y, t)(CVyt(δ,R))2 can potentially attain values higher than 1, adult
mortality decline will slow down and could even increase (expression (2)). In addition,
9 The assumption of an exponential decline of the force of mortality is harmless and considerably simplifies
the algebra.
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the observed slope of adult mortality will be lower than the slope in the baseline mortality
pattern (expression (3)).
2. Association between mortality markers at different ages
Since the magnitude of the attenuation of the rate of decline at adult ages will change
nonmonotonically across cohorts, delayed effects will induce correlations between a co-
hort’s early mortality and (i) the levels of adult mortality and (ii) the rate of change of
adult mortality with age. In a simplified model where standard frailty δ is distributed
as Γ(r,λ) and excess mortality associated with delayed effects is R > 1, the following
results apply:
1. The relation between the average force of mortality between an early age x and an
adult age ν older than a critical age Y is given by
µ¯(υ, t) = µ¯(x, t)
λ+ exp(−γt)Λs(x)
λ+ exp(−γt)Λs(ν,R))ϕs(υ,x, ε) (4)
where Λs(υ,R) =
∫ Y
0
µs(y)dy +R
∫ υ
Y
µs(y)dy and Λs(ν) =
∫ υ
0
µs(y)dy are the
integrated baseline hazards up to age υ with and without delayed effects, respec-
tively. The quantity ϕs(υ,x, ε) is a factor that transforms µs(x) into µs(υ) in a
one parameter-model life table, and ε is an indicator of the levels of mortality in
the baseline pattern.10 Because the factor that multiplies the quantity ϕs(υ,x, ε)
in expression (4) is less than 1, an OLS estimate of the regression coefficient of
ln(µ¯(υ, t)) on ln(µ¯(x, t)) estimated over a set of cohorts will yield a downwardly
biased estimate of the population parameter of interest, namely, ϕs(υ,x, ε). The
absolute value of the bias will increase with R and age and decrease over time.
As a consequence, the covariance between measures of child mortality and adult
mortality should drop for more recently born cohorts
2. Assume that the adult baseline mortality rates follow an exponential law with slope
β, that random frailty is Γ(r,λ), and excess mortality associated with delayed ef-
fects is R > 1. One can show that the estimate of the slope β will be the regression
coefficient in the following expression
µ¯(y, t) = µs(x
∗) exp(β(y − x∗))
(
r
λ+ exp(−γt)Λs(y,R)
)
(5)
where x∗ > Y is the age of onset of the exponential law of mortality. It follows
from first principles that the OLS estimate of β from the above expression will
10 In any of the four Coale–Demeny model patterns the unique parameter (mortality level) is life expectancy at
age 10.
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be downwardly biased, the bias will be larger when R is larger, and will decrease
as t → ∞. The consequence of this is that β should decline over time in cohorts
influenced by the secular mortality decline and, in addition, the covariance between
a measure of child mortality and β should be positive.
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Appendix 2: Hypothetical survival gains foregone due to delayed
effects
1. Approximation to expected gains foregone
We estimate the following relation:
lnM(x, t) = α+ β lnM(0, t) (6)
where M(x, t) is the mortality rate in an adult age group (x,x + k) for a cohort born
in year t and M(0, t) is the mortality rate in the age group 0–4 experienced by the same
cohort. According to the formal model, when there are delayed effects, the value of β
should decrease for more recently born cohorts as the inflow of individuals more suscep-
tible to express delayed effects at older ages increases. This swelling of susceptibility
will initially increase mortality rates in the youngest adult ages relative to the oldest,
thus lowering the value of β. Suppose that one compares cohorts born before and after
1935, and each is characterized by values of α and β. The key is to think of β as a
proportionate reduction of a cohort’s adult mortality rate – in the age interval (x,x + k)
– that would prevail given proportionate changes in a cohort mortality at age 0–4 when
delayed effects are weak (cohorts born before 1935, β1) and strong (cohorts born af-
ter 1935, β2). Suppose we observe the process during 20 years, a time interval during
which M(0, t) is changing at the rate of .01 per year. This means that the reduction in
the adult mortality rate M(x, t) is given by exp((β1/100) ∗ 20) when there are no de-
layed effects and exp((β2/100 ∗ 20) if there are delayed effects. If these magnitudes
hold for all ages older than x, and if the entropy of the survival curve in the background
mortality pattern is approximately .69, the foregone gains of life expectancy at age 60 are
pi(x) ∼ .69∗exp((β1/100)∗20)− .69∗ exp((β2/100)∗20) = .69∗exp((β1−β2)∗ .20).
When β2 < β1 this quantity is (approximately) the expected number of years of life after
age x that would be added in the absence of delayed effects or, alternatively, the gains
that will not be realized due to the presence of delayed effects.
The approximation to the value of pi depends on two assumptions. The first is that
the value of β is a constant for all ages older than x. The second is about the entropy
of the survival curve, namely the quantity E(x) =
∫
x
ln(Sx(y))Sx(y)dx/
∫
x
Sx(y)dx,
where Sx(y) is the conditional probability of surviving from age x to age y > x. There
is a relation between proportionate changes in the force of mortality at all ages older than
x and the change induced in life expectancy at that age, e(x). The relation is mediated
by the entropy of the survival curve above than age, E(x). This relation establishes that
a 1% increase (decrease) in the force of mortality at all ages above x translates into a
E(x) < 1% decrease (increase) in e(x). Since what is of interest to us are the effects
on old age mortality, the value if E(x) = .69 was computed numerically using x = 60
and the Coale–Demeny female West model life table with a life expectancy at birth of
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50 years. An illustration is as follows: suppose the values of β1 = .900 and β2 = .200.
The gains foregone should be given by pi ∼ .69* (exp(.900*.20) – exp(.200*.20))∼ .16
of what could have been gained. Thus, if the average value of E(60) hovers around 18
years – as it currently is in most LAC countries – the E(60) implied by a value of β = .9
in the absence of delayed effects is 18*1.19 = 21.4 years but only 18*1.041 = 18.73 when
there are delayed effects. This represents gains foregone of around 15% (close enough to
16% as implied by the expression). These magnitudes will of course vary with the value
chosen for x. For our purposes, however, this is unimportant since we are trying to offer
a more transparent interpretation of the estimates of the β′s (with and without delayed
effects) rather than compute exact values of gains or losses in life expectancy implied by
them.
2. Approximation to the variance of gains foregone
A general version of the approximation to the proportionate gains/losses of life expectancy
at age x imputed to absence/presence of delayed effects and embedded in the expression
relating M(x, t) and M(0, t) is
pi(x) ∼ E(x) ∗ exp((β1 − β2) ∗ .20)
where E(x) is the entropy of the survival curve most suitable to represent the age pattern
of mortality of various cohorts. The approximation only works if:
(i) (β1 − β2) is small,
(ii) the relation between M(x, t) and M(0, t) specified above holds for all ages above
x, and
(iii) the period of observation is 20 years.
The variance of pi(x) can be approximated by the Delta-method as Var(pi(x)) ∼
.04 ∗ E(x)2(Var(β1)+Var(β2)).
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